Press "esc" to clear
Go to Advanced Search

Showing results

110 of 103
juan-c-correa-gallego-hero-crop.jpg

Article ID: 705032

NYU Langone Hospital–Brooklyn Welcomes Cancer Surgeon and Skilled Researcher

NYU Langone Hospital - Brooklyn

Camilo Correa, MD, is a surgical oncologist specializing in liver, pancreas, bile duct, and intestinal cancers. A native of Colombia, Correa completed a postdoctoral research fellowship at Harvard Medical School and a clinical fellowship at Memorial Sloan Kettering Cancer Center.

Released:
6-Dec-2018 10:05 AM EST

Article ID: 704999

Engineered DNA-encoded PCSK9 Inhibitors May Provide an Effective Alternative for Treating High Cholesterol

Wistar Institute

Researchers at The Wistar Institute have developed novel synthetic DNA-encoded monoclonal antibodies (DMAbs) directed against PCSK9, a protein key to regulating cholesterol levels in the bloodstream.

Released:
5-Dec-2018 3:30 PM EST
SamanthaMorrisLab.jpg
  • Embargo expired:
    5-Dec-2018 1:00 PM EST

Article ID: 704900

Scientists Design Way to Track Steps of Cells’ Development

Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have developed a new tool described as a “flight data recorder” for developing cells, illuminating the paths cells take as they progress from one type to another. This cellular tracking device could one day help scientists guide cells along the right paths to regenerate certain tissues or organs, or help study the origins of cancer.

Released:
4-Dec-2018 1:05 PM EST
187500_web.jpg

Article ID: 704796

Genetic relic of the 'black death' may offer clues in treating liver disease

University of Cincinnati (UC) Academic Health Center

CINCINNATI--A gene mutation that is believed to have safeguarded some people in 14th century Europe from the bubonic plague today may be protecting HIV patients co-infected with hepatitis C from potentially fatal liver scarring, says a University of Cincinnati (UC) College of Medicine physician-scientist.

Released:
3-Dec-2018 1:25 PM EST
FrankBaker2_Web.jpg

Article ID: 704610

“A 4 percent chance is nothing to me”

University of Alabama at Birmingham

Former MLB player Frank Baker says his experience at UAB’s Pancreatobiliary Disease Center was a home run.

Released:
29-Nov-2018 10:05 AM EST

Article ID: 704477

Fatty Liver Disease

Houston Methodist

Millions of Americans have no idea that they have fatty liver disease. This growing problem will soon be the number one reason for liver transplantation, overtaking hepatitis C. Holiday overindulgence in alcohol and food could make the problem dramatically worse.

Released:
27-Nov-2018 12:05 PM EST
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703292

Universal Hepatitis C Screening of Pregnant Women More Cost-Effective Than Risk-Based Approach

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by The American Association for the Study of Liver Diseases – found that universal screening of pregnant women at risk for hepatitis C virus (commonly called HCV) infection is a more efficient and cost-effective diagnostic approach than risk-based screening.

Released:
2-Nov-2018 2:30 PM EDT
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703293

Nonalcoholic Fatty Liver Disease Patients Have Higher Rates of All Non-Liver-Related Cancers

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that rates of malignancy occurring outside of the liver were higher in adults with nonalcoholic fatty liver disease than among adults across most types of cancers.

Released:
2-Nov-2018 2:30 PM EDT
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703287

Liver Cancer Combined with Other Liver Diseases Driving Higher Death Rate and Health Care Costs for U.S. Seniors

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that hospitalizations and death are increasing among Medicare recipients with hepatocellular carcinoma, mainly due to co-existing alcoholic liver disease, hepatitis C virus infection (commonly called HCV) and nonalcoholic fatty liver disease (commonly called NAFLD).

Released:
2-Nov-2018 2:30 PM EDT
  • Embargo expired:
    9-Nov-2018 8:00 AM EST

Article ID: 703288

People with Hepatitis C Who Actively Inject Illegal Drugs Have High Rates of Hepatitis C Treatment Adherence and Cure

American Association for the Study of Liver Diseases (AASLD)

SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response. Based on these findings, researchers conclude these patients should be included in HCV treatment programs.

Released:
2-Nov-2018 2:30 PM EDT

Showing results

110 of 103

Chat now!